Amgen and Cytokinetics Announce Expansion of License for Omecamtiv Mecarbil Read more about Amgen and Cytokinetics Announce Expansion of License for Omecamtiv Mecarbil
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer Read more about Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting Read more about Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting
Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference Read more about Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma Read more about Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting Read more about Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
Amgen And Astellas Announce Japan Alliance Read more about Amgen And Astellas Announce Japan Alliance
Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference Read more about Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
Amgen Announces Voting Results of Annual Meeting of Stockholders Read more about Amgen Announces Voting Results of Annual Meeting of Stockholders
Amgen To Present At The UBS Global Life Sciences Conference Read more about Amgen To Present At The UBS Global Life Sciences Conference
